Dec 01, 2022 / 01:50PM GMT
Liisa Bayko - Evercore ISI - Analyst
Hi, good morning. My name is Liisa Bayko. Welcome to HealthCONx 2022. I'm very pleased today to be talking to Beam, which is one of the leaders in the gene editing space. And I would say the company has the coolest lab. We had a pleasure of visiting Beam in Boston as part of our bus tour last spring, and just love your labs. They're just so cool.
John Evans - Beam Therapeutics Inc. - CEO & Board Member
Thank you.
Questions and Answers:
Liisa Bayko - Evercore ISI - AnalystAnyone gets a chance to go there, I highly recommend. But I want to turn it over to you guys and maybe just to set the tone of the conversation. Maybe you can start with a quick overview of Beam.
John Evans - Beam Therapeutics Inc. - CEO & Board Member
Sure. So it's great to be here. Thank you. And yes, our labs are very cool. And everyone's welcome anytime. We're right in Cambridge. So Beam is a next-generation gene editing company. So we're using a new